◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

XORTX Therapeutics Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 0.00 0.00 0.00 0.00 0.00 --
Operating Revenue 0.00 0.00 0.00 0.00 0.00 --
Selling General And Administration 392,939 465,827 477,795 407,034 546,633 --
General And Administrative Expense 392,939 465,827 477,795 407,034 546,633 --
Research And Development 57,011 186,751 276,309 7,763 34,741 --
Depreciation And Amortization In Income Statement 29,385 27,630 25,985 26,144 25,949 --
Other Operating Expenses 236,862 209,737 183,367 220,323 267,426 --
Operating Expense 716,197 889,945 963,456 661,264 874,749 --
Operating Income -716,197 -889,945 -963,456 -661,264 -874,749 --
EBIT -716,197 -889,945 -963,456 -661,264 -874,749 --
Interest Income 7,201 12,326 18,421 -- 29,023 35,952
Interest Income Non Operating 7,201 12,326 18,421 -- 29,023 35,952
Net Interest Income 7,201 12,326 18,421 25,331 29,023 --
Other Income Expense 59,527 159,919 246,362 758,468 258,715 --
Gain On Sale Of Security 59,527 159,919 246,362 1.0M 258,715 --
Pretax Income -649,469 -717,700 -698,673 122,535 -587,011 --
Tax Effect Of Unusual Items 0.00 0.00 0.00 113,770 0.00 --
Net Income From Continuing And Discontinued Operation -649,469 -717,700 -698,673 122,535 -587,011 --
Net Income From Continuing Operation Net Minority Interest -649,469 -717,700 -698,673 122,535 -587,011 --
Net Income Including Noncontrolling Interests -649,469 -717,700 -698,673 122,535 -587,011 --
Net Income Common Stockholders -649,469 -717,700 -698,673 122,535 -587,011 --
Net Income -649,469 -717,700 -698,673 122,535 -587,011 --
EBITDA -686,812 -862,315 -937,471 -635,120 -848,800 --
Normalized EBITDA -746,339 -1.0M -1.2M -1.4M -1.1M --
Reconciled Depreciation 29,385 27,630 25,985 26,144 25,949 --
Basic EPS -0.13 -0.19 -0.19 -- -0.20 0.06
Diluted EPS -0.13 -0.19 -0.19 -- -0.20 0.06
Basic Average Shares 4.9M 3.8M 3.7M -- 2.9M 2.9M
Diluted Average Shares 4.9M 3.8M 3.7M -- 2.9M 2.9M
Total Unusual Items 59,527 159,919 246,362 758,468 258,715 --
Total Unusual Items Excluding Goodwill 59,527 159,919 246,362 758,468 258,715 --
Tax Rate For Calcs 0.00 0.00 0.00 0.15 0.00 --
Normalized Income -708,996 -877,619 -945,035 -522,163 -845,726 --
Amortization 6,497 6,789 6,521 6,631 6,389 --
Amortization Of Intangibles Income Statement 6,497 6,789 6,521 6,631 6,389 --
Depreciation Amortization Depletion Income Statement 29,385 27,630 25,985 26,144 25,949 --
Depreciation Income Statement 22,888 20,841 19,464 19,513 19,560 --
Diluted NI Availto Com Stockholders -649,469 -717,700 -698,673 122,535 -587,011 --
Net Income Continuous Operations -649,469 -717,700 -698,673 122,535 -587,011 --
Net Non Operating Interest Income Expense 7,201 12,326 18,421 25,331 29,023 --
Other Gand A 330,866 400,909 425,546 355,062 490,632 --
Salaries And Wages 62,073 64,918 52,249 51,972 56,001 --
Total Expenses 716,197 889,945 963,456 661,264 874,749 --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 1.2M 1.1M 1.9M 2.5M 2.3M --
Cash Cash Equivalents And Short Term Investments 1.2M 1.1M 1.9M 2.5M 2.3M --
Cash Equivalents 1.2M 947,724 1.8M 2.4M 2.2M --
Cash Financial 35,371 115,753 117,605 53,686 71,652 --
Accounts Receivable 22,092 10,860 17,252 17,637 13,111 --
Receivables 22,092 10,860 17,252 17,637 13,111 --
Prepaid Assets 30,444 97,589 190,949 185,412 96,536 --
Current Assets 1.4M 1.3M 2.1M 2.7M 2.4M --
Gross PPE 323,004 323,004 234,930 234,930 234,930 --
Accumulated Depreciation -263,402 -240,514 -219,673 -200,209 -180,696 --
Net PPE 59,602 82,490 15,257 34,721 54,234 --
Goodwill And Other Intangible Assets 193,997 195,008 179,972 183,108 185,703 --
Other Intangible Assets 193,997 195,008 179,972 183,108 185,703 --
Total Non Current Assets 1.5M 1.5M 1.4M 1.4M 1.4M --
Total Assets 2.8M 2.7M 3.5M 4.1M 3.9M --
Current Debt And Capital Lease Obligation 59,094 80,473 15,662 38,785 61,468 --
Accounts Payable 480,068 356,405 354,037 84,020 110,737 --
Payables 480,068 356,405 354,037 84,020 110,737 --
Payables And Accrued Expenses 677,314 453,982 415,688 147,205 326,283 --
Current Accrued Expenses 197,246 97,577 61,651 63,185 215,546 --
Other Current Liabilities 101,000 177,000 326,000 572,000 1.3M --
Current Liabilities 837,408 711,455 757,350 757,990 1.7M --
Total Non Current Liabilities Net Minority Interest 0.00 0.00 0.00 0.00 0.00 --
Total Liabilities Net Minority Interest 837,408 711,455 757,350 757,990 1.7M --
Common Stock 19.5M 18.9M 18.9M 18.5M 17.9M --
Capital Stock 19.5M 18.9M 18.9M 18.5M 17.9M --
Retained Earnings -23.2M -22.6M -21.9M -21.2M -21.3M --
Gains Losses Not Affecting Retained Earnings -52,605 5.7M -52,605 -52,605 -52,605 --
Other Equity Adjustments -52,605 5.7M -52,605 -52,605 -52,605 --
Common Stock Equity 2.0M 2.0M 2.7M 3.3M 2.1M --
Stockholders Equity 2.0M 2.0M 2.7M 3.3M 2.1M --
Total Equity Gross Minority Interest 2.0M 2.0M 2.7M 3.3M 2.1M --
Total Capitalization 2.0M 2.0M 2.7M 3.3M 2.1M --
Net Tangible Assets 1.8M 1.8M 2.6M 3.2M 1.9M --
Tangible Book Value 1.8M 1.8M 2.6M 3.2M 1.9M --
Working Capital 520,071 553,065 1.3M 1.9M 693,643 --
Invested Capital 2.0M 2.0M 2.7M 3.3M 2.1M --
Total Debt 59,094 80,473 15,662 38,785 61,468 --
Share Issued 5.2M 3.8M 3.8M 3.5M 2.9M --
Ordinary Shares Number 5.2M 3.8M 3.8M 3.5M 2.9M --
Buildings And Improvements 299,660 299,660 211,586 211,586 211,586 --
Capital Lease Obligations 59,094 80,473 15,662 38,785 61,468 --
Current Capital Lease Obligation 59,094 80,473 15,662 38,785 61,468 --
Current Deferred Assets 111,028 92,594 -- 0.00 0.00 48,104
Derivative Product Liabilities -- -- -- -- -- 1.6M
Non Current Accounts Receivable 1.2M 1.2M 1.2M 1.2M 1.2M --
Other Equity Interest 5.8M 24,746 5.7M 6.1M 5.6M --
Other Properties 23,344 23,344 23,344 23,344 23,344 --
Properties 0.00 0.00 0.00 0.00 0.00 --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow -629,617 -793,519 -643,730 -886,408 -751,851 --
Cash Flow From Continuing Operating Activities -629,617 -793,519 -643,730 -886,408 -751,851 --
Depreciation And Amortization 29,385 27,630 25,985 26,144 25,949 --
Depreciation Amortization Depletion 29,385 27,630 25,985 26,144 25,949 --
Stock Based Compensation 5,117 6,945 8,969 9,505 15,857 --
Change In Working Capital 56,012 65,807 266,942 -272,194 56,672 --
Changes In Account Receivables -11,232 6,392 385.00 -4,526 9,696 --
Change In Receivables -11,232 6,392 385.00 -4,526 9,696 --
Change In Payables And Accrued Expense 99.00 -30,160 268,309 -178,792 -111,882 --
Change In Other Working Capital -- -- -- -- 48,104 --
Other Non Cash Items -- -- -- -- 0.00 0.00
Capital Expenditure -5,486 -21,825 -3,385 -4,036 -23,181 --
Purchase Of PPE -- -- -- 0.00 0.00 0.00
Net PPE Purchase And Sale -- -- -- 0.00 0.00 0.00
Investing Cash Flow -5,486 -21,825 -3,385 -4,036 -23,181 --
Cash Flow From Continuing Investing Activities -5,486 -21,825 -3,385 -4,036 -23,181 --
Repayment Of Debt -21,379 -23,263 -23,123 -22,683 -22,238 --
Net Issuance Payments Of Debt -21,379 -23,263 -23,123 -22,683 -22,238 --
Issuance Of Capital Stock 1.0M 0.00 113,547 1.5M 0.00 --
Net Common Stock Issuance 1.0M 0.00 113,547 1.5M 0.00 --
Financing Cash Flow 770,879 -43,444 67,577 1.1M -22,238 --
Cash Flow From Continuing Financing Activities 770,879 -43,444 67,577 1.1M -22,238 --
Effect Of Exchange Rate Changes -5,338 27,027 1,127 -43,691 19,545 --
Changes In Cash 135,776 -858,788 -579,538 216,593 -797,270 --
Beginning Cash Position 1.1M 1.9M 2.5M 2.3M 3.1M --
End Cash Position 1.2M 1.1M 1.9M 2.5M 2.3M --
Free Cash Flow -635,103 -815,344 -647,115 -890,444 -775,032 --
Amortization Cash Flow 6,497 6,789 6,521 6,631 6,389 --
Amortization Of Intangibles 6,497 6,789 6,521 6,631 6,389 --
Change In Prepaid Assets 67,145 89,575 -1,752 67,736 110,754 --
Common Stock Issuance 1.0M 0.00 113,547 1.5M 0.00 --
Depreciation 22,888 20,841 19,464 19,513 19,560 --
Gain Loss On Investment Securities -76,000 -149,000 -246,000 -815,804 -244,000 --
Long Term Debt Payments -21,379 -23,263 -23,123 -22,683 -22,238 --
Net Foreign Currency Exchange Gain Loss 5,338 -27,201 -953.00 43,406 -19,318 --
Net Income From Continuing Operations -649,469 -717,700 -698,673 122,535 -587,011 --
Net Intangibles Purchase And Sale -5,486 -21,825 -3,385 -4,036 -23,181 --
Net Long Term Debt Issuance -21,379 -23,263 -23,123 -22,683 -22,238 --
Net Other Financing Charges -247,242 -20,181 -22,849 -370,276 0.00 --
Operating Gains Losses -70,662 -176,201 -246,953 -772,398 -263,318 --
Proceeds From Stock Option Exercised 0.00 0.00 2.00 3.00 0.00 --
Purchase Of Intangibles -5,486 -21,825 -3,385 -4,036 -23,181 --
NEWS
Loading news...
TRENDING
Loading...